Ozmosi | ipecacuanha Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

ipecacuanha

Alternative Names: ipecacuanha
Clinical Status: Inactive
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action:

Novel Mechanism: No

Modality: Unknown

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Australia | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | Croatia | Cyprus | Czech | Estonia | Finland | Germany | Greece | Hong Kong | Hungary | Indonesia | Ireland | Italy | Latvia | Lithuania | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Switzerland | Taiwan | Tunisia | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

Recent News Events

Date

Type

Title